William R. Weimar

1.1k total citations
41 papers, 1.0k citations indexed

About

William R. Weimar is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, William R. Weimar has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Genetics and 10 papers in Hematology. Recurrent topics in William R. Weimar's work include Polyamine Metabolism and Applications (13 papers), Iron Metabolism and Disorders (10 papers) and Hemoglobinopathies and Related Disorders (10 papers). William R. Weimar is often cited by papers focused on Polyamine Metabolism and Applications (13 papers), Iron Metabolism and Disorders (10 papers) and Hemoglobinopathies and Related Disorders (10 papers). William R. Weimar collaborates with scholars based in United States, Canada and Switzerland. William R. Weimar's co-authors include Raymond J. Bergeron, James S. McManis, Jan Wiegand, Allen H. Neims, Richard E. Smith, Otto Phanstiel, Yang Feng, J. R. Timothy Vinson, Carl W. Porter and Hua Yao and has published in prestigious journals such as Journal of the American Chemical Society, Brain Research and Journal of Bacteriology.

In The Last Decade

William R. Weimar

40 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William R. Weimar United States 18 562 275 245 144 144 41 1.0k
James S. McManis United States 25 947 1.7× 318 1.2× 547 2.2× 269 1.9× 266 1.8× 58 1.6k
Sandra J. Jordan United States 18 256 0.5× 97 0.4× 103 0.4× 58 0.4× 42 0.3× 24 977
P. R. Krishnaswamy India 17 491 0.9× 234 0.9× 33 0.1× 35 0.2× 32 0.2× 54 1.0k
Zhendong Jin United States 19 544 1.0× 55 0.2× 876 3.6× 18 0.1× 42 0.3× 47 1.4k
E. Vischer Switzerland 17 481 0.9× 46 0.2× 140 0.6× 51 0.4× 52 0.4× 24 884
Jan Wiegand United States 19 207 0.4× 32 0.1× 212 0.9× 437 3.0× 427 3.0× 44 922
Adelaide Faljoni‐Alário Brazil 21 582 1.0× 17 0.1× 121 0.5× 20 0.1× 39 0.3× 38 1.1k
Yandong Zhang China 23 468 0.8× 105 0.4× 966 3.9× 18 0.1× 10 0.1× 90 1.6k
Torsten Burkholz Germany 18 282 0.5× 167 0.6× 426 1.7× 11 0.1× 24 0.2× 27 1.0k
Pietro Allevi Italy 18 797 1.4× 77 0.3× 669 2.7× 11 0.1× 8 0.1× 122 1.3k

Countries citing papers authored by William R. Weimar

Since Specialization
Citations

This map shows the geographic impact of William R. Weimar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Weimar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Weimar more than expected).

Fields of papers citing papers by William R. Weimar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Weimar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Weimar. The network helps show where William R. Weimar may publish in the future.

Co-authorship network of co-authors of William R. Weimar

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Weimar. A scholar is included among the top collaborators of William R. Weimar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Weimar. William R. Weimar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergeron, Raymond J., Jan Wiegand, William R. Weimar, et al.. (2003). Iron chelation promoted by desazadesferrithiocin analogs: An enantioselective barrier. Chirality. 15(7). 593–599. 15 indexed citations
2.
Bergeron, Raymond J., et al.. (2003). Prevention of Acetic Acid-Induced Colitis by Desferrithiocin Analogs in a Rat Model. Digestive Diseases and Sciences. 48(2). 399–407. 2 indexed citations
3.
Bergeron, Raymond J., et al.. (2002). Structure-Activity Relationships Among Desazadesferrithiocin Analogues. Advances in experimental medicine and biology. 509. 167–184. 9 indexed citations
4.
Bergeron, Raymond J., et al.. (2001). Synthesis and Evaluation of Hydroxylated Polyamine Analogues as Antiproliferatives. Journal of Medicinal Chemistry. 44(15). 2451–2459. 18 indexed citations
5.
Bergeron, Raymond J., et al.. (2001). Significance of Asymmetric Sites in Choosing Siderophores as Deferration Agents. Journal of Medicinal Chemistry. 44(15). 2469–2478. 39 indexed citations
6.
Bergeron, Raymond J., William R. Weimar, & J Wiegand. (1999). Pharmacokinetics of Orally Administered Desferrithiocin Analogs in Cebus apella Primates. Drug Metabolism and Disposition. 27(12). 1496–1498. 7 indexed citations
7.
Bergeron, Raymond J., Jan Wiegand, William R. Weimar, & Patti S. Snyder. (1998). POLYAMINE ANALOGUE ANTIARRHYTHMICS. Pharmacological Research. 38(5). 367–380. 6 indexed citations
8.
Bergeron, Raymond J., et al.. (1998). The Origin of the Differences in (R)‐ and (S)‐Desmethyldesferrithiocin: Iron‐Clearing Propertiesa. Annals of the New York Academy of Sciences. 850(1). 202–216. 14 indexed citations
9.
Bergeron, Raymond J., et al.. (1998). Effect of Polyamine Analogues on Hypusine Content in JURKAT T-Cells. Journal of Medicinal Chemistry. 41(20). 3901–3908. 14 indexed citations
10.
Bergeron, Raymond J., et al.. (1998). Synthesis of Reagents for the Construction of Hypusine and Deoxyhypusine Peptides and Their Application as Peptidic Antigens. Journal of Medicinal Chemistry. 41(20). 3888–3900. 10 indexed citations
11.
Bergeron, Raymond J., et al.. (1997). The influence of molecular conformation upon the self-assembly of cyclohexane diamide diacids. Bioorganic & Medicinal Chemistry. 5(11). 2049–2061. 7 indexed citations
12.
Bergeron, Raymond J., William R. Weimar, G Luchetta, Charles A. Sninsky, & J Wiegand. (1996). Metabolism and pharmacokinetics of N1,N14-diethylhomospermine.. Drug Metabolism and Disposition. 24(3). 334–343. 3 indexed citations
13.
Bergeron, Raymond J., James S. McManis, William R. Weimar, et al.. (1995). The role of charge in polyamine analog recognition. Journal of Medicinal Chemistry. 38(13). 2278–2285. 48 indexed citations
14.
Bergeron, Raymond J., et al.. (1995). Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.. Drug Metabolism and Disposition. 23(10). 1117–1125. 22 indexed citations
15.
Bergeron, Raymond J., et al.. (1995). Impact of Polyamine Analogs on the NMDA Receptor. Journal of Medicinal Chemistry. 38(3). 425–428. 16 indexed citations
16.
Bergeron, Raymond J., James S. McManis, Yan Feng, et al.. (1994). Antiproliferative Properties of Polyamine Analogs: A Structure-Activity Study. Journal of Medicinal Chemistry. 37(21). 3464–3476. 71 indexed citations
17.
Sloan, Kenneth B., et al.. (1991). The effect of receptor phase composition on the permeability of hairless mouse skin in diffusion cell experiments. International Journal of Pharmaceutics. 73(2). 97–104. 60 indexed citations
18.
Bergeron, Raymond J. & William R. Weimar. (1990). Kinetics of iron acquisition from ferric siderophores by Paracoccus denitrificans. Journal of Bacteriology. 172(5). 2650–2657. 15 indexed citations
19.
Weimar, William R. & Allen H. Neims. (1977). The effects of postnatal hyper- and hypothyroidism on the development of d-amino acid oxidase in rat cerebellum and brain stem. Brain Research. 138(1). 139–150. 5 indexed citations
20.
Weimar, William R. & Allen H. Neims. (1977). THE DEVELOPMENT OF D‐AMINO ACID OXIDASE IN RAT CEREBELLUM. Journal of Neurochemistry. 29(4). 649–656. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026